Home/Filings/4/0001691102-25-000003
4//SEC Filing

Yea Christopher 4

Accession 0001691102-25-000003

CIK 0001348911other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 4:11 PM ET

Size

12.2 KB

Accession

0001691102-25-000003

Insider Transaction Report

Form 4
Period: 2025-11-17
Yea Christopher
CHIEF DEVELOPMENT OFFICER
Transactions
  • Sale

    Common Stock

    2025-11-18$14.48/sh2,683$38,848133,574 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-11-171,7743,548 total
    Common Stock (1,774 underlying)
  • Exercise/Conversion

    Common Stock

    2025-11-17+4,205136,257 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-11-172,4310 total
    Common Stock (2,431 underlying)
Footnotes (5)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
  • [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  • [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.16 to $14.4835 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through each vesting date.
  • [F5]1/12th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through each vesting date.

Issuer

KalVista Pharmaceuticals, Inc.

CIK 0001348911

Entity typeother

Related Parties

1
  • filerCIK 0001691102

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:11 PM ET
Size
12.2 KB